Rossari Biotech

Rossari Biotech ROE

The Return on Equity (ROE) of Rossari Biotech (ROSSARI.NS) as of Oct 12, 2026 is 11.19 %. In the previous year, Return on Equity (ROE) was 11.50 % — a change of -2.72% (lower).

ROE

11.19 %

YoY

-2.72%

Last updated:

In 2026, Rossari Biotech's return on equity (ROE) was 11.19 %, a -2.72% increase from the 11.50 % ROE in the previous year.

The Rossari Biotech ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
36.90 INR
Jan 1, 2020
22.76 INR
Jan 1, 2021
19.62 INR
Jan 1, 2022
12.13 INR
Jan 1, 2023
11.72 INR
Jan 1, 2024
12.47 INR
Jan 1, 2025
11.50 INR
Jan 1, 2026
11.19 INR
The Rossari Biotech ROE history
YEARROEYoY
11.19 %-2.72%
11.50 %-7.77%
12.47 %+6.43%
11.72 %-3.39%
12.13 %-38.19%
19.62 %-13.78%
22.76 %-38.31%
36.90 %+26.48%
29.17 %+26.58%
23.05 %+204.99%
7.56 %—
Access this data via the Eulerpool API
Get Free API Key

Rossari Biotech Stock analysis

What does Rossari Biotech do? Rossari Biotech is one of the most popular companies on Eulerpool.

ROE Details

Decoding Rossari Biotech's Return on Equity (ROE)

Rossari Biotech's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Rossari Biotech's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Rossari Biotech's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Rossari Biotech’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Rossari Biotech stock

Return on Equity (ROE) of Rossari Biotech is 11.19 % in 2026.

Return on Equity (ROE) of Rossari Biotech changed from 11.50 % to 11.19 %, representing a -2.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Rossari Biotech since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Rossari Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Rossari Biotech

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Rossari Biotech